A Phase 4, Multicenter, Randomized, Double-Blinded, Controlled Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients Undergoing Mandibular and Maxillary Procedures

First published 09/02/2016

Last updated 24/05/2024

EU PAS number:

EUPAS11647

Study

Finalised

Documents

Study protocol

Initial protocol

110902_FINAL Protocol Phase 4 OraVerse PHE-11-001 V4.0

English (1.37 MB - PDF)View document

Study results

150322_OraVerse_USPaedStudy_CSR_final_summary

English (258.73 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs